Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha Mitogen-Activated Protein Kinase Inhibitors
Hynes, J., Dyckman, A.J., Lin, S., Wrobleski, S.T., Wu, H., Gillooly, K.M., Kanner, S.B., Lonial, H., Loo, D., McIntyre, K.W., Pitt, S., Shen, D.R., Shuster, D.J., Yang, X., Zhang, R., Behnia, K., Zhang, H., Marathe, P.H., Doweyko, A.M., Tokarski, J.S., Sack, J.S., Pokross, M., Kiefer, S.E., Newitt, J.A., Barrish, J.C., Dodd, J., Schieven, G.L., Leftheris, K.
J.Med.Chem.
